CAT and neoplasm: Therefore, the development of anticancer agents with antioxidant features may improve their efficacy by modulating the redox balance either by triggering antioxidant defense, such as glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT), or selectively augmenting oxidative damage in tumor cells.7 In parallel, inflammation is closely relevant to oxidative stress in cancer.